Kither Biotech S.r.l
Kither Biotech is a pharma product company focused on the development of new drugs for the treatment of chronic inflammation and cancer.
Kither Biotech is a pharmaceutical product company, focused on the development of new drugs targeting PI3K enzymes involved in inflammation and cancer. Kither is committed to develop new molecules blocking PI3K for the treatment of chronic obstructive pulmonary disease, psoriasis and breast cancer. With these drugs, Kither intends to explore options for commercial exploitation, possibly through licensing agreements with pharmaceutical companies.